Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Transplant. Mar 24, 2014; 4(1): 18-29
Published online Mar 24, 2014. doi: 10.5500/wjt.v4.i1.18
Published online Mar 24, 2014. doi: 10.5500/wjt.v4.i1.18
ABO incompatible renal transplants: Good or bad?
Masaki Muramatsu, Magdi M Yaqoob, Carmelo Puliatti, Department of Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom
Masaki Muramatsu, Atsushi Aikawa, Department of Nephrology, Toho University Faculty of Medicine, Tokyo 143-8541, Japan
Hector Daniel Gonzalez, Roberto Cacciola, Magdi M Yaqoob, Carmelo Puliatti, Transplant Unit, The Royal London Hospital, London E1 1BB, United Kingdom
Author contributions: Muramatsu M, Cacciola R, Aikawa A, Yaqoob MM and Puliatti C contributed to conception and design, acquisition of data, or analysis and interpretation of data; Muramatsu M, Gonzalez HD, Cacciola R, Aikawa A, Yaqoob MM and Puliatti C contributed to drafting the article or revising it critically for important intellectual content; Muramatsu M, Yaqoob MM and Puliatti C contributed to final approval of the version to be published.
Correspondence to: Carmelo Puliatti, MD, Transplant Unit, The Royal London Hospital, Whitechapel Road, London E1 1BB, United Kingdom. Carmelo.Puliatti@bartshealth.nhs.uk
Telephone: +44-20-35942673 Fax: +44-20-35943248
Received: December 7, 2013
Revised: February 12, 2014
Accepted: February 18, 2014
Published online: March 24, 2014
Revised: February 12, 2014
Accepted: February 18, 2014
Published online: March 24, 2014
Core Tip
Core tip: This article demonstrates merits and demerits of ABO incompatible kidney transplantation (ABOi-KT). Although the excellent outcome of ABOi-KT has been achieved, unresolved matters still remain. We review the role of ABOi-KT for patients with end-stage kidney disease and considered validity whether ABOi-KT should be recommended as a therapeutic option of KT in the future.